{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-033491","form_type":"8-K","ticker":"CYRX","cik":"0001124524","company_name":"Cryoport, Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.454572+00:00","generated_at":"2026-06-04T22:47:57.519392+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cryoport FY 2023 revenue $233.3M (-2% YoY); net loss $99.6M; guides FY 2024 $242-252M","bullets":["Q4 revenue $57.3M (-5% YoY); FY revenue $233.3M (-2% YoY). Services grew 8% but product fell 14%.","Net loss for FY $99.6M includes $49.6M goodwill impairment; adjusted EBITDA negative $8.3M vs positive $13.9M prior year.","Commercial Cell & Gene therapy revenue up 33% YoY; BioStorage/BioServices up 45%; record 675 clinical trials supported.","FY 2024 revenue guidance $242-252M; expects progressive growth.","Cash, equivalents & short-term investments $456.8M; $36M remaining under $100M repurchase program."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-033491","json":"https://secwatch.observer/filing/0001104659-24-033491.json","markdown":"https://secwatch.observer/filing/0001104659-24-033491.md","text":"https://secwatch.observer/filing/0001104659-24-033491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/0001104659-24-033491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/tm248611d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:47:57.519392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ab605bf46e273a1ec7b6ee99e1059e049742f43","claim":"Cryoport, Inc. reported the fiscal year ended December 31, 2023 results: revenue $233.3 million.","evidence_excerpt":"Today we reported full year results including total revenue of $233.3 million for the fiscal year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/0001104659-24-033491-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$233.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b6483524ae618313952defce783ee457b4dffe21","claim":"Cryoport, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $57.3 million.","evidence_excerpt":"Total revenue for Q4 2023 was $57.3 million compared to $60.4 million for Q4 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/0001104659-24-033491-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$57.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}